What is Veil.ai?
VEIL.AI specializes in transforming sensitive health data into high-quality, anonymized, and synthetic datasets that comply with GDPR and HIPAA regulations. Their AI-driven technology enables safe and efficient utilization of sensitive data for research, clinical trials, and AI development across various sectors including pharmaceuticals, research hospitals, and health data authorities. VEIL.AI's solutions enhance data privacy while maximizing its analytical value, supporting global collaborations and innovation in healthcare. Trusted by leading organizations, VEIL.AI stands at the forefront of privacy-enhancing technologies in the health data landscape.
How much funding has Veil.ai raised?
Veil.ai has raised a total of $1.3M across 1 funding round:
Debt
$1.3M
Debt (2022): $1.3M with participation from BioInnovation Institute
Key Investors in Veil.ai
BioInnovation Institute
BioInnovation Institute is dedicated to supporting changemakers who envision transformative possibilities in life sciences, focusing on accelerating research and startups. They provide substantial funding and resources to early-stage ventures and academic researchers.
What's next for Veil.ai?
The recent major enterprise-level funding positions Veil.ai for significant expansion and further development of its AI-driven synthetic data solutions. This strategic capital infusion is expected to accelerate its market penetration within the pharmaceutical and healthcare research sectors, enabling broader adoption of its privacy-preserving technologies. The company's focus on regulatory compliance, such as GDPR and HIPAA, combined with its advanced anonymization capabilities, provides a strong foundation for future growth and innovation in the sensitive health data domain.
See full Veil.ai company page
